ERCC1 and non-small cell lung carcinoma: When compared with the variant genotypes (C/A + A/A), the wild-type ERCC1 (C/C) in rs3212986 locus was reported to exhibit longer median progression free survival among NSCLC patients with platinum-based chemotherapy (Grenda et al., 2020).